title: Successful treatment with vemurafenib in BRAF V600K-positive cerebral melanoma metastasis.
authors.forename: Andrea
authors.initials: A
authors.lastname: Forschner
authors.forename: Heike
authors.initials: H
authors.lastname: Niessner
authors.forename: Juergen
authors.initials: J
authors.lastname: Bauer
authors.forename: Benjamin
authors.initials: B
authors.lastname: Bender
authors.forename: Claus
authors.initials: C
authors.lastname: Garbe
authors.forename: Friedegund
authors.initials: F
authors.lastname: Meier
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008545:Melanoma / Q000235:genetics / Q000556:secondary / Q000628:therapy*; D008875:Middle Aged; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics / Q000473:pathology* / Q000601:surgery; D013449:Sulfonamides / Q000627:therapeutic use*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf